Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. [electronic resource]
Producer: 20080902Description: 1331-1335 p. digitalISSN:- 1569-8041
- Adult
- Anthracyclines -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- metabolism
- Antigens, CD34 -- analysis
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bleomycin -- administration & dosage
- Bone Marrow Purging -- methods
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Genes, bcl-2
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Mobilization
- Humans
- Immunologic Factors -- administration & dosage
- Immunosuppressive Agents -- administration & dosage
- Kaplan-Meier Estimate
- Lymphoma, Follicular -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Peripheral Blood Stem Cell Transplantation
- Recurrence
- Remission Induction
- Rituximab
- Time Factors
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.